Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8880 | 1140 | 43.4 | 85% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
897 | 10655 | CARDIOTROPHIN 1//JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY//HYPERTROPHY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | FORCE FREQUENCY RELATIONSHIP | Author keyword | 17 | 39% | 3% | 34 |
2 | FORCE FREQUENCY RELATION | Author keyword | 14 | 49% | 2% | 21 |
3 | D DAVIS HEART LUNG | Address | 12 | 75% | 1% | 9 |
4 | HUMAN MYOCARDIUM | Author keyword | 8 | 24% | 3% | 29 |
5 | SERCA2A | Author keyword | 5 | 20% | 2% | 22 |
6 | CARDIAC GENE THERAPY | Author keyword | 5 | 63% | 0% | 5 |
7 | MYOTHERMAL MEASUREMENTS | Author keyword | 4 | 75% | 0% | 3 |
8 | SARCOPLASMIC RETICULUM CALCIUM ATPASE | Author keyword | 4 | 44% | 1% | 7 |
9 | CARDIAC GENE EXPRESSION | Author keyword | 3 | 27% | 1% | 11 |
10 | CARDIOVASCULAR GENE TRANSFER | Author keyword | 3 | 100% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FORCE FREQUENCY RELATIONSHIP | 17 | 39% | 3% | 34 | Search FORCE+FREQUENCY+RELATIONSHIP | Search FORCE+FREQUENCY+RELATIONSHIP |
2 | FORCE FREQUENCY RELATION | 14 | 49% | 2% | 21 | Search FORCE+FREQUENCY+RELATION | Search FORCE+FREQUENCY+RELATION |
3 | HUMAN MYOCARDIUM | 8 | 24% | 3% | 29 | Search HUMAN+MYOCARDIUM | Search HUMAN+MYOCARDIUM |
4 | SERCA2A | 5 | 20% | 2% | 22 | Search SERCA2A | Search SERCA2A |
5 | CARDIAC GENE THERAPY | 5 | 63% | 0% | 5 | Search CARDIAC+GENE+THERAPY | Search CARDIAC+GENE+THERAPY |
6 | MYOTHERMAL MEASUREMENTS | 4 | 75% | 0% | 3 | Search MYOTHERMAL+MEASUREMENTS | Search MYOTHERMAL+MEASUREMENTS |
7 | SARCOPLASMIC RETICULUM CALCIUM ATPASE | 4 | 44% | 1% | 7 | Search SARCOPLASMIC+RETICULUM+CALCIUM+ATPASE | Search SARCOPLASMIC+RETICULUM+CALCIUM+ATPASE |
8 | CARDIAC GENE EXPRESSION | 3 | 27% | 1% | 11 | Search CARDIAC+GENE+EXPRESSION | Search CARDIAC+GENE+EXPRESSION |
9 | CARDIOVASCULAR GENE TRANSFER | 3 | 100% | 0% | 3 | Search CARDIOVASCULAR+GENE+TRANSFER | Search CARDIOVASCULAR+GENE+TRANSFER |
10 | CA PUMP | 3 | 28% | 1% | 10 | Search CA+PUMP | Search CA+PUMP |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HUMAN DILATED CARDIOMYOPATHY | 43 | 47% | 6% | 69 |
2 | CA 2 ATPASE GENE | 34 | 41% | 6% | 65 |
3 | STAGE HEART FAILURE | 21 | 23% | 7% | 79 |
4 | SARCOPLASMIC RETICULUM CA2 ATPASE | 18 | 15% | 10% | 109 |
5 | FORCE FREQUENCY RELATION | 18 | 39% | 3% | 36 |
6 | PHOSPHOLAMBAN | 15 | 15% | 8% | 93 |
7 | FAILING HUMAN MYOCARDIUM | 13 | 18% | 6% | 66 |
8 | NONFAILING HUMAN MYOCARDIUM | 11 | 34% | 2% | 27 |
9 | FORCE FREQUENCY RELATIONSHIP | 10 | 26% | 3% | 32 |
10 | CALCIUM UP REGULATION | 9 | 39% | 2% | 19 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Potential of gene therapy as a treatment for heart failure | 2013 | 16 | 83 | 58% |
Alterations of calcium-regulatory proteins in heart failure | 1998 | 267 | 85 | 51% |
Abnormalities of calcium cycling in the hypertrophied and failing heart | 2000 | 205 | 83 | 53% |
Sarcoplasmic reticulum Ca2+ ATPase as a therapeutic target for heart failure | 2010 | 45 | 77 | 39% |
Calcium cycling in congestive heart failure | 2002 | 228 | 144 | 38% |
Gene Therapy for Heart Failure | 2012 | 38 | 145 | 31% |
Sarcoendoplasmic Reticulum Calcium Transport ATPase 2a A Potential Gene Therapy Target in Heart Failure | 2013 | 5 | 19 | 79% |
Cardiac Gene Therapy: Optimization of Gene Delivery Techniques In Vivo | 2010 | 14 | 49 | 69% |
Force-frequency relationship in intact mammalian ventricular myocardium: physiological and pathophysiological relevance | 2004 | 88 | 83 | 47% |
SERCA pump level is a critical determinant of Ca2+ homeostasis and cardiac contractility | 2001 | 119 | 63 | 46% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | D DAVIS HEART LUNG | 12 | 75% | 0.8% | 9 |
2 | ABT KARDIOL PNEUMOL | 3 | 13% | 1.7% | 19 |
3 | BOWMAN GRAY MED CARDIOL SECT | 2 | 67% | 0.2% | 2 |
4 | COEUR BIOCHEM | 2 | 67% | 0.2% | 2 |
5 | INTEGRATED PHYSIOL S | 2 | 67% | 0.2% | 2 |
6 | PROGRAM CARDIOVASC GENE THER YCARDIOVASC CT | 2 | 67% | 0.2% | 2 |
7 | SANGER HEART VASC | 2 | 20% | 0.8% | 9 |
8 | MUSCLE MOL CARDIOL | 2 | 13% | 1.1% | 13 |
9 | MOL CELLULAR CARDIOL S | 1 | 50% | 0.2% | 2 |
10 | STRITCH MED CARDIOVASC | 1 | 100% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000281749 | PHOSPHOLAMBAN//SARCOLIPIN//PHARMACOL CELL BIOPHYS |
2 | 0.0000157476 | BDF 9148//DPI 201 106//NA CHANNEL MODULATORS |
3 | 0.0000121642 | CARDIOMYOPATHIC HAMSTERS//CARDIOMYOPATHIC HAMSTER//HAMSTER CARDIOMYOPATHY |
4 | 0.0000121059 | GAZES CARDIAC//DETYROSINATED//MOSSAKOWSKI EXPT CLIN MED |
5 | 0.0000120012 | T 0509//ZINTEROL//BETA ADRENERGIC RECEPTOR SUBTYPE |
6 | 0.0000103142 | CORONARY ARTERY NARROWING//VENTRICULAR FAILURE//BALKE BIODYNAM |
7 | 0.0000091395 | TRANSIENT OUTWARD CURRENT//KCHIP//KV42 |
8 | 0.0000090361 | DELAYED AFTERDEPOLARIZATIONS//OVERDRIVE EXCITATION//RAT CARDIAC TRABECULAE |
9 | 0.0000089525 | RYANODINE RECEPTOR//SARCOPLASMIC RETICULUM//EXCITATION CONTRACTION COUPLING |
10 | 0.0000089004 | AMBULATORY RADIONUCLIDE MONITORING//PAIRED PACING//AMBULATORY CARDIAC MONITORING |